Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hercules Capital, Inc. (NYSE: HTGC) SEC filings page provides access to the company’s official disclosures as a reporting company and business development company. Hercules Capital files documents such as Current Reports on Form 8-K, which describe material events including quarterly earnings announcements, cash distribution declarations, and shareholder meeting results. These filings supplement the company’s press releases and give investors structured information about its operations and governance.
Recent Form 8-K filings show how Hercules Capital reports results of operations and financial condition for specific quarters, with references to earnings press releases furnished as exhibits. These filings also document decisions by the board of directors to declare quarterly total cash distributions per share, including the stated distribution amount and key dates for record and payment. By reviewing these filings, investors can track the company’s distribution practices and timing over time.
Hercules Capital’s SEC filings also cover corporate governance matters. For example, a Form 8-K describing the annual meeting of stockholders details proposals submitted to shareholders, such as the election of directors, advisory votes on named executive officer compensation, authorization to sell or issue shares below net asset value under specified conditions, and ratification of the independent public accountant. The filing reports vote counts for each proposal, providing transparency into shareholder decisions.
Filings list Hercules Capital’s jurisdiction of incorporation as Maryland and confirm that its common stock and 6.25% Notes due 2033 are registered under Section 12(b) of the Securities Exchange Act of 1934 and traded on the New York Stock Exchange under the symbols HTGC and HCXY, respectively. These details help investors verify the company’s capital structure and listing status.
On this page, AI-powered tools can assist by summarizing lengthy filings, highlighting key items such as earnings announcements, distribution declarations, and shareholder vote outcomes, and pointing to relevant exhibits. This can help readers quickly understand the main points of Hercules Capital’s 8-Ks and related disclosures while retaining the ability to review the full original documents from EDGAR.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported an open-market purchase of 7,000 shares of common stock. The average purchase price was $14.35 per share, with trades executed between $14.30 and $14.36. Following this transaction, he directly owns 2,516,379 common shares.
Hercules Capital director Wade Loo, through the Loo Revocable Trust, bought 3,300 shares of common stock in an open-market purchase at $14.98 per share. After this indirect purchase, the trust held 32,767 shares, and Loo also held 6,630 shares directly.
Hercules Capital, Inc. director Robert P. Badavas reported an open‑market purchase of 5,000 shares of common stock on behalf of the Robert P. Badavas Trust of 2007. The shares were bought at an average purchase price with trades executed between $15.01 and $15.02 per share.
After this transaction, the trust held a total of 117,073 Hercules Capital shares indirectly attributed to Badavas, while he also held 1,412 shares directly. This filing reflects a net increase in his overall reported ownership position in the company.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.
After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.
Hercules Capital, Inc. director Gayle A. Crowell reported an open-market purchase of common stock. On February 23, 2026, Crowell bought 6,600 shares at a price of $15.20 per share. After this transaction, Crowell directly owned 87,458 shares of Hercules Capital common stock. The reported ownership total includes shares previously acquired through the company’s dividend reinvestment plan.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein bought 30,000 shares of common stock in an open-market purchase. The shares were acquired at an average price of $15.08 each, with individual trade prices ranging from $15.04 to $15.10. Following this transaction, Bluestein directly owns 2,509,379 shares of Hercules Capital common stock.
Hercules Capital director Nikos Theodosopoulos bought 6,165 shares of common stock in an open-market purchase. The transaction took place on February 17, 2026, at an average price of $15.93 per share. Following this purchase, his directly owned stake increased to 18,923 shares.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 20,000 shares of Common Stock on February 17, 2026, at an average price of $15.88 per share. A footnote explains the price reflects purchases between $15.81 and $15.92.
The 20,000 shares are held by the Fallon Family Revocable Trust, bringing its indirect holdings to 120,369 shares. Separately, Fallon directly holds 5,779 shares, which reflects his personal stake outside the trust.
Hercules Capital, Inc. reported record full-year 2025 results, with total investment income of $532.5 million, up 7.9% year-over-year, and net investment income of $341.7 million, or $1.91 per share, up 4.9%. Total gross debt and equity commitments reached $3.92 billion and gross fundings $2.28 billion.
In Q4 2025, total investment income was $137.4 million and net investment income was $87.0 million, or $0.48 per share, providing 120% coverage of the base cash distribution. Net asset value per share rose to $12.13 on 182.7 million shares.
The Board declared a fourth quarter 2025 total cash distribution of $0.47 per share, including a $0.40 base and $0.07 supplemental distribution, payable on March 4, 2026 to holders of record on February 25, 2026. A new supplemental cash distribution of $0.28 per share will be paid in four equal quarterly installments beginning with this quarter.
Hercules ended Q4 2025 with $525.5 million of available liquidity and a debt investment portfolio at fair value of $4.28 billion, 89.3% in first-lien senior secured loans and 97.9% floating rate. Loans on non-accrual fell to one position, representing 0.2% of the portfolio at cost. Subsequent to year-end, the company issued $300.0 million of 5.350% unsecured notes due 2029.
HCXY’s filing outlines a large, highly diversified investment portfolio centered on senior secured debt, plus related equity and warrant positions. The portfolio spans application software, drug discovery and development, healthcare services, consumer and business services, sustainable technology, space technology, semiconductors and more.
Most debt investments are floating-rate loans tied to 1- or 3‑month SOFR, Prime, or SONIA with substantial credit spreads, floor rates, and frequent payment‑in‑kind (PIK) and exit fee features, and maturities generally running from 2025 into the early 2030s. HCXY also holds numerous preferred and common equity stakes, as well as warrants, in many of the same portfolio companies, and participates in investment funds and foreign currency contracts.
The text also highlights structural risks, including security interests on assets securing senior securities, potential volatility if preferred stock or convertible debt is issued, lack of an active trading market for certain notes, SBIC regulatory oversight of subsidiaries, and the possibility that capital market disruptions or tariff changes could negatively affect portfolio companies.